ASeq Newsletter
Subscribe
Sign in
Home
Archive
About
More
return
;
New
Top
Pleno Inc.
Pleno recently came out of Stealth and announced a $15M round for their seemingly PCR-like but not PCR platform. There’s almost no information available…
Nava Whiteford
May 26
2
Comment
Share
Share this post
Pleno Inc.
aseq.substack.com
Copy link
Twitter
Facebook
Email
More Thoughts on Qitan Technology
After my post on Qitan there were a few comments on twitter that I thought might be worth addressing. The first suggested that “this is not an ASIC…
Nava Whiteford
May 15
Comment
Share
Share this post
More Thoughts on Qitan Technology
aseq.substack.com
Copy link
Twitter
Facebook
Email
Thoughts on Chinese nanopore startups
I’ve recently looked at 4 Chinese nanopore sequencing startups: AxBio, Genvida, RH Genetech, and Qitan Technology. In this post I’m going to briefly…
Nava Whiteford
May 13
Comment
Share
Share this post
Thoughts on Chinese nanopore startups
aseq.substack.com
Copy link
Twitter
Facebook
Email
Qitan Technology
The final, and potentially most interesting of the three Chinese nanopore startups I’ve recently been looking at is Qitan Technology. For a nanopore…
Nava Whiteford
May 11
3
Comment
Share
Share this post
Qitan Technology
aseq.substack.com
Copy link
Twitter
Facebook
Email
RH Genetech
While looking into Chinese nanopore companies I came across RH Genetech. The company appears to sell a number of instruments including air sampling LAMP…
Nava Whiteford
Apr 10
3
Comment
Share
Share this post
RH Genetech
aseq.substack.com
Copy link
Twitter
Facebook
Email
Genvida - Solidstate nanogap sequencing
This week I’m planning to look at a few different Chinese nanopore sequencing startups. There are in fact, a surprising number of them. I’ve previously…
Nava Whiteford
Apr 4
2
Comment
Share
Share this post
Genvida - Solidstate nanogap sequencing
aseq.substack.com
Copy link
Twitter
Facebook
Email
Element Biosciences - Further Thoughts
A few things came up after my last post on Element. Firstly, over on twitter it was noted that Element have said they use a “multivalent binding…
Nava Whiteford
Mar 24
1
Comment
Share
Share this post
Element Biosciences - Further Thoughts
aseq.substack.com
Copy link
Twitter
Facebook
Email
Element Biosciences - Chemistry
UPDATE: Over on twitter, Simon Barnett pointed me toward this patent, which describes a related approach. Most of the conclusions in this post hold, but…
Nava Whiteford
Mar 20
Comment
Share
Share this post
Element Biosciences - Chemistry
aseq.substack.com
Copy link
Twitter
Facebook
Email
Element Biosciences - Launch Review
A few people have asked me about Elements’ recent announcements. You can find an excellent overview of the launch at OmicsOmics. For my own part (which…
Nava Whiteford
Mar 17
1
Comment
Share
Share this post
Element Biosciences - Launch Review
aseq.substack.com
Copy link
Twitter
Facebook
Email
Chemistry X and Long Reads
Of Illumina’s recent announcements, Chemistry X seemed the most interesting to me. Not really because this is a significant leap forward, but because of…
Nava Whiteford
Mar 7
Comment
Share
Share this post
Chemistry X and Long Reads
aseq.substack.com
Copy link
Twitter
Facebook
Email
Reticula Pt. 3 - Technological Approach
In the first post on Reticula I described my fund raising adventures and in part 2 I described the motivation for low cost ($1 COGS, $500 instrument…
Nava Whiteford
Feb 22
3
Comment
Share
Share this post
Reticula Pt. 3 - Technological Approach
aseq.substack.com
Copy link
Twitter
Facebook
Email
Reticula Pt. 2 - COVID19 and Sequencing
In my previous post I discussed the background to Reticula and all the fun I’ve had trying to fundraise. In this post I wanted to discuss COVID19 and…
Nava Whiteford
Feb 21
2
Comment
Share
Share this post
Reticula Pt. 2 - COVID19 and Sequencing
aseq.substack.com
Copy link
Twitter
Facebook
Email
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts